Unusual Comorbid Conditions in Three Children with Congenital Dysfibrinogenemia: Lymphedema, Leukemia, and Sternal Defect

Zühre Kaya; Onur Özdemir; Gülsüm Kayhan; Özgür Akdemir

doi:10.1055/a-2574-8705

Seminars in Thrombosis and Hemostasis, Table of Contents

Semin Thromb Hemost
DOI: 10.1055/a-2574-8705

Letter to the Editor

Unusual Comorbid Conditions in Three Children with Congenital Dysfibrinogenemia: Lymphedema, Leukemia, and Sternal Defect

Zühre Kaya

¹Department of Pediatric Hematology, Faculty of Medicine, Gazi University, Ankara, Türkiye

,

Onur Özdemir

¹Department of Pediatric Hematology, Faculty of Medicine, Gazi University, Ankara, Türkiye

,

Gülsüm Kayhan

²Department of Medical Genetics, Faculty of Medicine, Gazi University, Ankara, Türkiye

,

Özgür Akdemir

³Department of Nuclear Medicine, Faculty of Medicine, Gazi University, Ankara, Türkiye

› Author Affiliations

Abstract

Full Text

References

References
1 Mackie I, Casini A, Pieters M, Pruthi R, Reilly-Stitt C, Suzuki A. International council for standardisation in haematology recommendations on fibrinogen assays, thrombin clotting time and related tests in the investigation of bleeding disorders. Int J Lab Hematol 2024; 46 (01) 20-32
2 Casini A. From routine to research laboratory: strategies for the diagnosis of congenital fibrinogen disorders. Hamostaseologie 2020; 40 (04) 460-466
3 Xiang L, Luo M, Yan J. et al. Combined use of Clauss and prothrombin time-derived methods for determining fibrinogen concentrations: Screening for congenital dysfibrinogenemia. J Clin Lab Anal 2018; 32 (04) e22322
4 Miesbach W, Schenk J, Alesci S, Lindhoff-Last E. Comparison of the fibrinogen Clauss assay and the fibrinogen PT derived method in patients with dysfibrinogenemia. Thromb Res 2010; 126 (06) e428-e433
5 Casini A, de Moerloose P. How I treat dysfibrinogenemia. Blood 2021; 138 (21) 2021-2030
6 Mohsenian S, Palla R, Menegatti M. et al. Congenital fibrinogen disorders: a retrospective clinical and genetic analysis of the Prospective Rare Bleeding Disorders Database. Blood Adv 2024; 8 (06) 1392-1404
7 Casini A, Moerloose P, Neerman-Arbez M. Clinical, laboratory, and molecular aspects of congenital fibrinogen disorders. Semin Thromb Hemost 2025; 51 (02) 103-110
8 Li Y, Ding B, Wang X, Ding Q. Congenital (hypo-)dysfibrinogenemia and bleeding: A systematic literature review. Thromb Res 2022; 217: 36-47
9 Mudun A. Lymphedema and peripheral lymphoscintigraphy. J Ist Faculty Med 2024; 87 (03) 253-260
10 Mackie J, Lawrie AS, Kitchen S. et al. A performance evaluation of commercial fibrinogen reference preparations and assays for Clauss and PT-derived fibrinogen. Thromb Haemost 2002; 87 (06) 997-1005
11 Haverkate F, Samama M. Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen. Thromb Haemost 1995; 73 (01) 151-161
12 Tian D, Liang J, Gao H. et al. Clinical phenotype and laboratory characteristics of 93 patients with congenital fibrinogen disorders from unrelated 36 families. Res Pract Thromb Haemost 2024; 8 (04) 102445
13 Kumar K, Patel S, Chiang KY. et al. Hiding in plain sight: Diagnosing congenital dysfibrinogenemia in a child presenting with acute myeloid leukemia. Pediatr Blood Cancer 2021; 68 (07) e29050
14 Kirihara T, Fujikawa Y, Takeda W. et al. [Congenital dysfibrinogenemia coincidentally diagnosed at the onset of chronic myelogenous leukemia]. Rinsho Ketsueki 2014; 55 (05) 541-545